The 36-month beta value for ZVSA is also noteworthy at 0.68. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ZVSA is 0.75M, and at present, short sellers hold a 6.14% of that float. The average trading volume of ZVSA on May 07, 2024 was 394.64K shares.
ZVSA) stock’s latest price update
The stock of ZyVersa Therapeutics Inc (NASDAQ: ZVSA) has increased by 17.25 when compared to last closing price of 5.45.Despite this, the company has seen a gain of 10.75% in its stock price over the last five trading days. PennyStocks reported 2024-02-27 that Investing in penny stocks offers a unique opportunity for investors looking to expand their portfolios with potentially high-reward options. Recognized for their affordability, these stocks allow individuals to purchase shares in emerging companies without a significant financial outlay.
ZVSA’s Market Performance
ZyVersa Therapeutics Inc (ZVSA) has experienced a 10.75% rise in stock performance for the past week, with a -12.90% drop in the past month, and a 4.75% rise in the past quarter. The volatility ratio for the week is 14.51%, and the volatility levels for the past 30 days are at 12.90% for ZVSA. The simple moving average for the past 20 days is 4.15% for ZVSA’s stock, with a -74.93% simple moving average for the past 200 days.
ZVSA Trading at -15.36% from the 50-Day Moving Average
After a stumble in the market that brought ZVSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.11% of loss for the given period.
Volatility was left at 12.90%, however, over the last 30 days, the volatility rate increased by 14.51%, as shares sank -12.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.22% lower at present.
During the last 5 trading sessions, ZVSA rose by +10.75%, which changed the moving average for the period of 200-days by -91.59% in comparison to the 20-day moving average, which settled at $6.09. In addition, ZyVersa Therapeutics Inc saw -29.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ZVSA
The total capital return value is set at -8.02. Equity return is now at value -177.00, with -139.81 for asset returns.
Based on ZyVersa Therapeutics Inc (ZVSA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -1007.49. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is 172555.92.
Currently, EBITDA for the company is -14.41 million with net debt to EBITDA at -0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.33.
Conclusion
In summary, ZyVersa Therapeutics Inc (ZVSA) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
